PRKCA and type 2 diabetes mellitus: This T2DM-activated PKC-α intersects with MAPK14 and ADAM17, fostering the proteolytic shedding of proinflammatory cytokines, which amplifies glial reactivity and disrupts sympathetic homeostasis [30,57].